Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study
- PMID: 17890459
- PMCID: PMC2946895
- DOI: 10.1378/chest.07-1205
Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study
Abstract
Background: Exercise-induced hypoxemia is frequent in patients with lymphangioleiomyomatosis (LAM) and could be associated with pulmonary hypertension. The aims of this study were to determine the prevalence of pulmonary hypertension in patients with LAM, to identify physiologic parameters associated with its occurrence, and to evaluate the effect of oxygen on response to exercise.
Methods: Studies were performed in 120 patients. Complete data, including exercise echocardiography, pulmonary function testing, and standard cardiopulmonary exercise testing, were obtained in 95 patients.
Results: Resting pulmonary artery pressure (PAP) was 26+/-0.7 mm Hg (mean+/-SEM). Eight patients had pulmonary hypertension (43+/-3 mm Hg), and two patients had right ventricular dilatation. Ninety-five patients exercised (room air, n=64; oxygen, n=31) to a power of 58+/-2 W (49% of predicted) and an estimated peak oxygen uptake of 938+/-30 mL/min (56% of predicted). Sixty-one patients had a decline in arterial oxygen saturation (SaO2)>3%, and 56 patients had an elevation in PAP>40 mm Hg. Peak exercise PAP was negatively correlated with exercise Sao2 (p=0.0005). Multivariate analysis showed that exercise SaO2 was the best predictor of exercise PAP (p=0.012).
Conclusions: Although resting pulmonary hypertension is rare in patients with LAM, a rise in PAP at low exercise levels occurs frequently, in part related to exercise-induced hypoxemia. Optimization of oxygen administration during activities of daily living should be undertaken in patients with LAM to prevent hypoxemia and exercise-induced pulmonary hypertension.
Figures
Similar articles
-
Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography.J Am Soc Echocardiogr. 2018 Aug;31(8):888-901. doi: 10.1016/j.echo.2018.02.004. Epub 2018 Mar 28. J Am Soc Echocardiogr. 2018. PMID: 29605474
-
Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.Front Med. 2019 Apr;13(2):259-266. doi: 10.1007/s11684-018-0634-z. Epub 2018 Apr 19. Front Med. 2019. PMID: 29675687
-
Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.Kardiol Pol. 2011;69(1):9-15. Kardiol Pol. 2011. PMID: 21267956
-
Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis.Int J Cardiovasc Imaging. 2021 Feb;37(2):439-448. doi: 10.1007/s10554-020-02009-x. Epub 2020 Sep 14. Int J Cardiovasc Imaging. 2021. PMID: 32929608
-
Pulmonary arterial pressure at rest and during exercise in chronic mountain sickness: a meta-analysis.Eur Respir J. 2019 Jun 27;53(6):1802040. doi: 10.1183/13993003.02040-2018. Print 2019 Jun. Eur Respir J. 2019. PMID: 31023845
Cited by
-
Desaturation-Distance Ratio During Submaximal and Maximal Exercise Tests and Its Association With Lung Function Parameters in Patients With Lymphangioleiomyomatosis.Front Med (Lausanne). 2021 Jul 29;8:659416. doi: 10.3389/fmed.2021.659416. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34395465 Free PMC article.
-
Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.Curr Treat Options Cardiovasc Med. 2017 Jun;19(6):44. doi: 10.1007/s11936-017-0543-5. Curr Treat Options Cardiovasc Med. 2017. PMID: 28466120 Review.
-
EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.Expert Opin Orphan Drugs. 2016;4(4):369-378. doi: 10.1517/21678707.2016.1148597. Epub 2016 Mar 7. Expert Opin Orphan Drugs. 2016. PMID: 27833825 Free PMC article.
-
[Histopathological aspects of pulmonary hypertension].Pathologe. 2012 May;33(3):183-91. doi: 10.1007/s00292-011-1560-x. Pathologe. 2012. PMID: 22318487 German.
-
Lymphangioleiomyomatosis: differential diagnosis and optimal management.Ther Clin Risk Manag. 2014 Aug 21;10:691-700. doi: 10.2147/TCRM.S50784. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 25187723 Free PMC article. Review.
References
-
- Kitaichi M, Nishimura K, Harumi I, et al. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995;151:527–533. - PubMed
-
- Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest. 1998;114:1689–1703. - PubMed
-
- Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest. 1999;115:1041–1052. - PubMed
-
- Urban TJ, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis: a study of 69 patients. Medicine. 1999;78:321–337. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials